In a new post on @PhRMA’s blog, our own Michael Petroutsas highlights how the #Medicare Prescription Payment Plan can help some seniors better manage their expenses and adhere to their prescribed treatments. https://t.co/yinsC2MWtM

We’re excited to be at the @ASH_hematology Annual Meeting to present new data that reinforces our progress in FLT3m+ acute myeloid leukemia (AML) care. Visit our booth #2031 to hear more. #ASH25 Read more: https://t.co/5Fm7gekbUu

From lighting our Northbrook HQ in periwinkle to attending inspiring summits with our advocacy partners, November was filled with impactful activities for #StomachCancerAwarenessMonth. Together, we’re committed to creating change for this community! 💜

This National Family History Awareness Day, we're spotlighting the connection between hereditary health patterns and geographic atrophy (GA). Having a family history of GA increases risk of vision loss – knowing your family background is the first step.​ For U.S. Audiences Only

Adults with muscle-invasive #BladderCancer who are ineligible for cisplatin-based chemotherapy have long faced few treatment options, but the landscape is changing. Learn more about our new FDA approval for these patients: https://t.co/dgKoFJWMtW For U.S. audiences only.

If you or a loved one is facing a #StomachCancer diagnosis, know that you are not alone. Hearing insights from patients, caregivers, & healthcare providers can help. Watch more on GI Cancer Chronicles: https://t.co/wifu76k5uI #StomachCancerAwarenessMonth For U.S. audiences only

At Astellas, on this year's #WorldScienceDay, we celebrate bold ideas, breakthrough innovation & the pursuit of what’s never been done. Watch how we’re pioneering science to change tomorrow. #ChangingTomorrow #AstellasPioneeringScience

Providing physical and emotional support, caregivers embody strength and resilience. Sue, a care partner to her husband Dan for many years, offers her advice for others supporting a loved one living with #ProstateCancer. See more: https://t.co/X5RKZqsJ80 For U.S. audiences only

Attending OSN New York & Retina? Be sure to stop by booth #1 and don’t miss the symposia featuring R. Ross Lakhanpal, MD, FACS, FASRS and Carl Danzig, MD to learn more about protecting healthy retina cells for longer in patients with geographic atrophy.​ For U.S. Audiences Only

At a recent @StatBrandStudio Open Doors event hosted by Astellas, industry leaders explored how partnership and open innovation keep the Boston biotech community at the cutting edge of global innovation. Find out more: https://t.co/CTjfr5BbdM #ChangingTomorrrow

Thank you to those who visited our booth at @MenopauseOrg! We're energized by the conversations around women’s health care. Your insights will help shape our commitment to innovative solutions for women experiencing moderate to severe vasomotor symptoms due to menopause. #TMS25

Hot flashes and night sweats due to menopause aren’t just uncomfortable, they’re a real medical condition that can be treated. At Astellas, we are dedicated to research that helps women address some of the challenges of their menopausal journeys. https://t.co/T7Jwb0GznZ #TMS25

Just Announced: a supplemental biologics license application (sBLA) for our therapy for certain patients with muscle-invasive bladder cancer has been accepted by the U.S. FDA and granted priority review. #BladderCancer See more: https://t.co/fr1qqObPFG For U.S. Audiences Only

Visit our booth #303 at @MenopauseOrg to discover how our latest research is exploring the unique challenges women face when experiencing hot flashes and night sweats due to menopause. #TMS25

We’re excited to present new Phase 1 data from our #TargetedProteinDegradation pipeline at #Targets25. Learn more about our TPD efforts here: https://t.co/O59LSXO4E5. Hope to see you there!

We’re excited to present data at @MenopauseOrg 2025 in Orlando. Our team is dedicated to impacting women’s health care through innovation. Learn more: https://t.co/5QDtjHScNE #TMS25

Today at #ESMO25 and in the New England Journal of Medicine: new overall survival data in a form of non-metastatic hormone-sensitive #ProstateCancer. Learn more about this development in our 10+ years of research in this space: https://t.co/SFxtq2Uma3 For U.S. audiences only.

We're presenting positive survival results in cisplatin-ineligible patients with muscle-invasive bladder cancer from a Phase 3 trial with Pfizer and Merck today at #ESMO25. Learn about our work in advancing #BladderCancer care: https://t.co/Yn5YJPH8Ye For U.S. audiences only.

Our Menopause Experience & Attitudes Study has shown that menopause may substantially affect women’s mental health, often stemming from limited awareness. The #WorldMenopauseDay theme “Lifestyle Medicine” reminds us to combat stigma and support the wellbeing of women in midlife.

Astellas leaders recently shared their views with @endpts on pioneering allogeneic #celltherapies to restore sight in those affected by retinal diseases like geographic atrophy: https://t.co/QXG8dJ4jZE #ChangingTomorrow #AstellasPioneeringScience